Curable (XKRX:086460) EV-to-Revenue : (As of Sep. 26, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Curable EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Curable's enterprise value is ₩19,167.0 Mil. Curable does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in Dec. 2023. Therefore, GuruFocus does not calculate Curable's EV-to-Revenue at this moment.

The historical rank and industry rank for Curable's EV-to-Revenue or its related term are showing as below:

XKRX:086460' s EV-to-Revenue Range Over the Past 10 Years
Min: -2.63 Med: 40 Max: 137.67
Current: 90.53

During the past 3 years, the highest EV-to-Revenue of Curable was 137.67. The lowest was -2.63. And the median was 40.00.

XKRX:086460's EV-to-Revenue is ranked worse than
96.74% of 215 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.17 vs XKRX:086460: 90.53

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-09-26), Curable's stock price is ₩3205.00. Curable does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023. Therefore, GuruFocus does not calculate Curable's PS Ratio at this moment.

Curable EV-to-Revenue Historical Data

The historical data trend for Curable's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curable EV-to-Revenue Chart

Curable Annual Data

Trend

Dec21

Dec22

Dec23

EV-to-Revenue

-2.09

62.18

136.98

Curable Semi-Annual Data
	Dec21	Dec22	Dec23
EV-to-Revenue	-	62.18	136.98

Competitive Comparison of Curable's EV-to-Revenue

For the Diagnostics & Research subindustry, Curable's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curable's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Curable's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Curable's EV-to-Revenue falls into.

Curable EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Curable's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	19167.024	/
	=

Curable (XKRX:086460) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Curable's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	3205.00	/
	=

Curable EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Curable's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Curable Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Curable Inc (XKRX:086460) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

93, Dongtan-daero 23-gil, 10th Floor, Gyeonggi-do, Hwaseong-si, KOR

Website

http://www.snp-genetics.com

Curable Inc provides genome analysis service.

Curable Headlines

No Headlines